🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
Urothelial carcinoma (UC) is the ninth most common cancer type worldwide. W...
Status
Active Not Recruiting
Location
Highlands Oncology Group - Springdale /ID# 270290
Start Date
2025-01-20
Trial ID
NCT06632951
Treatments Being Tested
Lung cancer is the leading cause of cancer-related deaths worldwide. Accord...
Status
Recruiting
Location
Anhui cancer hospital
Start Date
2025-10-30
Trial ID
NCT07330596
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Indiana University Cancer Center
Start Date
1999-08-11
Trial ID
NCT00003810
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Start Date
2000-03
Trial ID
NCT00014456
Treatments Being Tested
The purpose of this study is to test the combination of the chemotherapy dr...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2010-09
Trial ID
NCT01106872
Treatments Being Tested
Ridaforolimus has been tested in almost 2 dozen studies; however, it has no...
Status
Withdrawn
Location
Cancer Therapy & Research Center at UTHSCSA
Start Date
2011-02
Trial ID
NCT01296659
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop tumor cells from divi...
Status
Completed
Location
Gynecologic Oncology Group
Start Date
2005-01
Trial ID
NCT00031629
Treatments Being Tested
This is a dose escalation safety study of birinapant (TL32711) in combinati...
Status
Completed
Location
Holy Cross Hospital
Start Date
2010-10
Trial ID
NCT01188499
Treatments Being Tested